cardiexcardiexcardiexcardiex
  • Solutions
    • Use Cases
      • Healthcare
      • Drug and Device Development
      • Academia/Research
      • Wellness and Longevity
    • Therapies
      • Hypertension
      • Renal Disease
      • Heart Failure
      • Maternal Health
      • Brain Health
      • Metabolic Health
      • COPD
      • Men’s Health
      • Sports Medicine
    • Products
      • CONNEQT Pulse
      • SphygmoCor XCEL
      • Oscar 2
      • Digital Solutions
    • SphygmoCor Technology
  • Company
    • About
    • Board & Management
    • Corporate Governance
    • News & Media
    • Events & Tradeshows
    • Technology & IP
  • Investors
  • Resources
    • Sample Case Studies
    • Clinical Research Repository
    • Customer Support
  • Solutions
    • Use Cases
      • Healthcare
      • Drug and Device Development
      • Academia/Research
      • Wellness and Longevity
    • Therapies
      • Hypertension
      • Renal Disease
      • Heart Failure
      • Maternal Health
      • Brain Health
      • Metabolic Health
      • COPD
      • Men’s Health
      • Sports Medicine
    • Products
      • CONNEQT Pulse
      • SphygmoCor XCEL
      • Oscar 2
      • Digital Solutions
    • SphygmoCor Technology
  • Company
    • About
    • Board & Management
    • Corporate Governance
    • News & Media
    • Events & Tradeshows
    • Technology & IP
    • Careers
  • Investors
  • Resources
    • Case Studies
    • Clinical Research Repository
    • Customer Support
  • Legal
    • Privacy Policy
    • Disclaimer
    • Acceptable Use Policy
Contact Us
✕
            No results See all results

            Company

            SphygmoCor by the Numbers

            Top 20

            All “Top 20 Hospitals” use SphygmoCor technology to measure central blood pressure (cBP)

            2,400+

            SphygmoCor technology has supported studies that have resulted in over 2,400+ peer-reviewed publications.

            8/10

            8 out of top 10 Pharma companies have used SphygmoCor technology in their clinical trials

            11,000

            Over 11,000 patients have been tested with SphygmoCor technology in pharmaceutical trials

            AHA Health Tech Finalist
            Company

            Company
            • About
            • Board & Management
            • Corporate Governance
            • News & Media
            • Events & Tradeshows
            • Careers
            Legal
            • Privacy Policy
            • Disclaimer
            • Acceptable Use Policy

            Company
            DTRA

            The Cardiex group of companies is pleased to be a member of these esteemed professional organizations.
            Copyright © 2024 Cardiex. All Rights Reserved.

            Contact Us
                      No results See all results